{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:15:53Z","timestamp":1790320553379,"version":"4.1.0"},"reference-count":145,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01AI141889"],"award-info":[{"award-number":["R01AI141889"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008213","name":"South Dakota State University","doi-asserted-by":"publisher","award":["3AH-477"],"award-info":[{"award-number":["3AH-477"]}],"id":[{"id":"10.13039\/100008213","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IIA1335423"],"award-info":[{"award-number":["IIA1335423"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Influenza causes millions of cases of hospitalizations annually and remains a public health concern on a global scale. Vaccines are developed and have proven to be the most effective countermeasures against influenza infection. Their efficacy has been largely evaluated by hemagglutinin inhibition (HI) titers exhibited by vaccine-induced neutralizing antibodies, which correlate fairly well with vaccine-conferred protection. Contrarily, non-neutralizing antibodies and their therapeutic potential are less well defined, yet, recent advances in anti-influenza antibody research indicate that non-neutralizing Fc-effector activities, especially antibody-dependent cellular cytotoxicity (ADCC), also serve as a critical mechanism in antibody-mediated anti-influenza host response. Monoclonal antibodies (mAbs) with Fc-effector activities have the potential for prophylactic and therapeutic treatment of influenza infection. Inducing mAbs mediated Fc-effector functions could be a complementary or alternative approach to the existing neutralizing antibody-based prevention and therapy. This review mainly discusses recent advances in Fc-effector functions, especially ADCC and their potential role in influenza countermeasures. Considering the complexity of anti-influenza approaches, future vaccines may need a cocktail of immunogens in order to elicit antibodies with broad-spectrum protection via multiple protective mechanisms.<\/jats:p>","DOI":"10.3390\/v12030276","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T03:13:28Z","timestamp":1583205208000},"page":"276","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function"],"prefix":"10.3390","volume":"12","author":[{"given":"Rongyuan","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Biology and Microbiology, South Dakota State University, Brookings, SD 57007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhang","family":"Sheng","sequence":"additional","affiliation":[{"name":"Zuckerman Institute, Columbia University, New York, NY 10027, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chithra C.","family":"Sreenivasan","sequence":"additional","affiliation":[{"name":"Department of Biology and Microbiology, South Dakota State University, Brookings, SD 57007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7263-8420","authenticated-orcid":false,"given":"Dan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biology and Microbiology, South Dakota State University, Brookings, SD 57007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biology and Microbiology, South Dakota State University, Brookings, SD 57007, USA"},{"name":"BioSNTR, Brookings, SD 57007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"ref_1","unstructured":"WHO (2017). Up to 650,000 People Die of Respiratory Diseases Linked to Seasonal Flu Each Year, WHO."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e00031-14","DOI":"10.1128\/mBio.00031-14","article-title":"Characterization of a novel influenza virus in cattle and Swine: Proposal for a new genus in the Orthomyxoviridae family","volume":"5","author":"Hause","year":"2014","journal-title":"MBio"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Hause, B.M., Ducatez, M., Collin, E.A., Ran, Z., Liu, R., Sheng, Z., Armien, A., Kaplan, B., Chakravarty, S., and Hoppe, A.D. (2013). Isolation of a novel swine influenza virus from Oklahoma in 2011 which is distantly related to human influenza C viruses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003176"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.32607\/20758251-2009-1-2-26-32","article-title":"Influenza virus neuraminidase: Structure and function","volume":"1","author":"Shtyrya","year":"2009","journal-title":"Acta Nat."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tong, S., Zhu, X., Li, Y., Shi, M., Zhang, J., Bourgeois, M., Yang, H., Chen, X., Recuenco, S., and Gomez, J. (2013). New world bats harbor diverse influenza A viruses. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003657"},{"key":"ref_7","unstructured":"CDC, and Weekly, U.S. (2020). Influenza Surveillance Report, Key Updates for Week 7, Ending 15 February."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","article-title":"Influenza vaccines: Challenges and solutions","volume":"17","author":"Houser","year":"2015","journal-title":"Cell Host Microbe"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6803a1","article-title":"Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2019\u20132020 Influenza Season","volume":"68","author":"Grohskopf","year":"2019","journal-title":"MMWR Recomm. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4049\/jimmunol.1400432","article-title":"Influenza-specific antibody-dependent cellular cytotoxicity: Toward a universal influenza vaccine","volume":"193","author":"Jegaskanda","year":"2014","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3389\/fimmu.2019.01457","article-title":"Influenza and Antibody-Dependent Cellular Cytotoxicity","volume":"10","author":"Moody","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Asthagiri Arunkumar, G., Ioannou, A., Wohlbold, T.J., Meade, P., Aslam, S., Amanat, F., Ayllon, J., Garcia-Sastre, A., and Krammer, F. (2019). Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice. J. Virol., 93.","DOI":"10.1128\/JVI.01696-18"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chom.2016.05.014","article-title":"Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection","volume":"19","author":"Leon","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3389\/fimmu.2019.01677","article-title":"Protective Antibodies Against Influenza Proteins","volume":"10","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/infdis\/jiw262","article-title":"Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge","volume":"214","author":"Jegaskanda","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.vaccine.2016.11.082","article-title":"Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection","volume":"35","author":"Nieuwkoop","year":"2017","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ofid\/ofw102","article-title":"Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans","volume":"3","author":"Zhong","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1073\/pnas.89.8.3659","article-title":"Tyrosine phosphorylation of phospholipase C-gamma 1 induced by cross-linking of the high-affinity or low-affinity Fc receptor for IgG in U937 cells","volume":"89","author":"Liao","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2013.09.007","article-title":"Granzyme B ELISPOT assay to measure influenza-specific cellular immunity","volume":"398","author":"Salk","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nri2744","article-title":"Monoclonal antibodies: Versatile platforms for cancer immunotherapy","volume":"10","author":"Weiner","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Anand, S.P., and Finzi, A. (2019). Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections. Vaccines, 7.","DOI":"10.3390\/vaccines7030103"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.iy.09.040191.002325","article-title":"Fc receptors","volume":"9","author":"Ravetch","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.immuni.2005.05.010","article-title":"FcgammaRIV: A novel FcR with distinct IgG subclass specificity","volume":"23","author":"Nimmerjahn","year":"2005","journal-title":"Immunity"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.1203954109","article-title":"Mouse model recapitulating human Fcgamma receptor structural and functional diversity","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2015.03.255","article-title":"Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases","volume":"67","author":"Irani","year":"2015","journal-title":"Mol. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinthera.2008.01.014","article-title":"Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer","volume":"30","author":"Wu","year":"2008","journal-title":"Clin. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: From structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4161\/mabs.1.6.10185","article-title":"IgG2m4, an engineered antibody isotype with reduced Fc function","volume":"1","author":"An","year":"2009","journal-title":"MAbs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","article-title":"Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes","volume":"13","author":"Bondt","year":"2014","journal-title":"Mol. Cell Proteom."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1023\/A:1018582930906","article-title":"Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum","volume":"14","author":"Yamada","year":"1997","journal-title":"Glycoconj. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.aids.0000161767.21405.68","article-title":"Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals","volume":"19","author":"Moore","year":"2005","journal-title":"AIDS"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000479980","article-title":"Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy","volume":"44","author":"Kellner","year":"2017","journal-title":"Transfus. Med. Hemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4161\/mabs.27854","article-title":"Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody","volume":"6","author":"Monnet","year":"2014","journal-title":"MAbs"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.qai.0000230318.40170.60","article-title":"An adenovirus-based HIV subtype B prime\/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains","volume":"43","author":"Florese","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tim.2017.10.007","article-title":"Impact of HIV-1 Envelope Conformation on ADCC Responses","volume":"26","author":"Richard","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2006.04.010","article-title":"Antibodies from patients with dengue viral infection mediate cellular cytotoxicity","volume":"37","author":"Garcia","year":"2006","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, M., Daniel, S., Huang, Y., Chancey, C., Huang, Q., Lei, Y.F., Grinev, A., Mostowski, H., Rios, M., and Dayton, A. (2010). Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol., 11.","DOI":"10.1186\/1471-2172-11-3"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Pitisuttithum","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/21645515.2016.1276138","article-title":"Progress in HIV vaccine development","volume":"13","author":"Hsu","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/COH.0000000000000439","article-title":"Anti-HIV-1 antibody-dependent cellular cytotoxicity: Is there more to antibodies than neutralization?","volume":"13","author":"Lee","year":"2018","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Bruel, T., Guivel-Benhassine, F., Lorin, V., Lortat-Jacob, H., Baleux, F., Bourdic, K., Noel, N., Lambotte, O., Mouquet, H., and Schwartz, O. (2017). Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies. J. Virol., 91.","DOI":"10.1128\/JVI.02440-16"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/scitranslmed.3007736","article-title":"Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines","volume":"6","author":"Chung","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_59","first-page":"91","article-title":"Enhancement of antibody-dependent cell mediated cytotoxicity: A new era in cancer treatment","volume":"4","author":"Rajasekaran","year":"2015","journal-title":"Immuno Targets Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2012.07.006","article-title":"Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity","volume":"384","author":"Kramski","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mullarkey, C.E., Bailey, M.J., Golubeva, D.A., Tan, G.S., Nachbagauer, R., He, W., Novakowski, K.E., Bowdish, D.M., Miller, M.S., and Palese, P. (2016). Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner. MBio, 7.","DOI":"10.1128\/mBio.01624-16"},{"key":"ref_62","first-page":"362","article-title":"A mechanism for neutrophil-mediated lysis of human neuroblastoma cells","volume":"53","author":"Barker","year":"1993","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.016","article-title":"A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples","volume":"366","author":"Ackerman","year":"2011","journal-title":"J. Immunol. Methods"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4049\/jimmunol.179.1.337","article-title":"Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity","volume":"179","author":"Horner","year":"2007","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1126\/science.147.3660.873","article-title":"Contact-Induced Cytotoxicity by Lymphoid Cells Containing Foreign Isoantigens","volume":"147","author":"Moeller","year":"1965","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3389\/fimmu.2019.01025","article-title":"Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1","volume":"10","author":"Lewis","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.144.9.3375","article-title":"Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects","volume":"144","author":"Tyler","year":"1990","journal-title":"J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/jvi.52.1.223-230.1984","article-title":"Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity","volume":"52","author":"Kurane","year":"1984","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1128\/JVI.00273-13","article-title":"Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus","volume":"87","author":"Srivastava","year":"2013","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fimmu.2017.00317","article-title":"Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice","volume":"8","author":"Ye","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(90)90259-X","article-title":"A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells","volume":"135","author":"Radosevic","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"ref_73","first-page":"3","article-title":"Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity","volume":"217","author":"Nieuwkoop","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14234","DOI":"10.1038\/ncomms14234","article-title":"A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action","volume":"8","author":"Chai","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1182\/blood-2012-08-453738","article-title":"LAMP1\/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity","volume":"121","author":"Krzewski","year":"2013","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAI.0b013e31822c62b9","article-title":"Activation of NK cells by ADCC antibodies and HIV disease progression","volume":"58","author":"Chung","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4161\/hv.23446","article-title":"Activation of NK cells by HIV-specific ADCC antibodies: Role for granulocytes in expressing HIV-1 peptide epitopes","volume":"9","author":"Madhavi","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2014.07.010","article-title":"Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies","volume":"414","author":"Cheng","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Tan, G.S., Leon, P.E., Albrecht, R.A., Margine, I., Hirsh, A., Bahl, J., and Krammer, F. (2016). Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005578"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/22221751.2018.1564369","article-title":"Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model","volume":"8","author":"Amanat","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2016.00399","article-title":"HA Antibody-Mediated FcgammaRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids","volume":"7","author":"Cox","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ermler, M.E., Kirkpatrick, E., Sun, W., Hai, R., Amanat, F., Chromikova, V., Palese, P., and Krammer, F. (2017). Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model. J. Virol., 91.","DOI":"10.1128\/JVI.00286-17"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.coviro.2013.07.007","article-title":"Influenza virus hemagglutinin stalk-based antibodies and vaccines","volume":"3","author":"Krammer","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1128\/JVI.00469-12","article-title":"A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo","volume":"86","author":"Tan","year":"2012","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2144\/000114041","article-title":"Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses","volume":"54","author":"Desbien","year":"2013","journal-title":"Biotechniques"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Wang, T.T., Tan, G.S., Hai, R., Pica, N., Petersen, E., Moran, T.M., and Palese, P. (2010). Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000796"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Yasugi, M., Kubota-Koketsu, R., Yamashita, A., Kawashita, N., Du, A., Sasaki, T., Nishimura, M., Misaki, R., Kuhara, M., and Boonsathorn, N. (2013). Human monoclonal antibodies broadly neutralizing against influenza B virus. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003150"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.celrep.2017.08.084","article-title":"Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in VH1-69 Antibody Orientation on the HA Stem","volume":"20","author":"Lang","year":"2017","journal-title":"Cell Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.antiviral.2013.03.021","article-title":"Broadly neutralizing antibodies against influenza viruses","volume":"98","author":"Laursen","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.coviro.2016.02.002","article-title":"Novel universal influenza virus vaccine approaches","volume":"17","author":"Krammer","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npjvaccines.2016.15","article-title":"A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice","volume":"1","author":"Nachbagauer","year":"2016","journal-title":"NPJ Vaccines"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2017.02.009","article-title":"Universal influenza virus vaccines and therapeutic antibodies","volume":"23","author":"Nachbagauer","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"DiLillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Brandenburg, B., Koudstaal, W., Goudsmit, J., Klaren, V., Tang, C., Bujny, M.V., Korse, H.J., Kwaks, T., Otterstrom, J.J., and Juraszek, J. (2013). Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080034"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shen, C., Chen, J., Li, R., Zhang, M., Wang, G., Stegalkina, S., Zhang, L., Chen, J., Cao, J., and Bi, X. (2017). A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses. Sci. Transl. Med., 9.","DOI":"10.1126\/scitranslmed.aam5752"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.tim.2017.12.003","article-title":"Influenza H3N2 Vaccines: Recent Challenges","volume":"26","author":"Mostafa","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.09.6","article-title":"Universal M2 ectodomain-based influenza A vaccines: Preclinical and clinical developments","volume":"8","author":"Schotsaert","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1093\/infdis\/jiz017","article-title":"Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection","volume":"219","author":"Eichelberger","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: A growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","article-title":"Broadly protective human antibodies that target the active site of influenza virus neuraminidase","volume":"366","author":"Stadlbauer","year":"2019","journal-title":"Science"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1021\/bi9008837","article-title":"Structure and function of the influenza A M2 proton channel","volume":"48","author":"Cady","year":"2009","journal-title":"Biochemistry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.bbamem.2010.04.015","article-title":"Influenza M2 proton channels","volume":"1808","author":"Pielak","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.vaccine.2012.03.021","article-title":"Immunization with high epitope density of M2e derived from 2009 pandemic H1N1 elicits protective immunity in mice","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"Descamps","year":"2011","journal-title":"J. Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7774\/cevr.2014.3.1.12","article-title":"New vaccines against influenza virus","volume":"3","author":"Lee","year":"2014","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2018.03.024","article-title":"Vaccine options for influenza: Thinking small","volume":"53","author":"Schepens","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12310","article-title":"Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination","volume":"143","author":"Lee","year":"2014","journal-title":"Immunology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/14760584.2017.1240041","article-title":"M2-based influenza vaccines: Recent advances and clinical potential","volume":"16","author":"Kolpe","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2014.08.016","article-title":"Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates","volume":"111","author":"Song","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/266052a0","article-title":"Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells","volume":"266","author":"Virelizier","year":"1977","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.4049\/jimmunol.126.5.1814","article-title":"Expression of influenza A virus internal antigens on the surface of infected P815 cells","volume":"126","author":"Yewdell","year":"1981","journal-title":"J. Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Antrobus, R.D., Lillie, P.J., Berthoud, T.K., Spencer, A.J., McLaren, J.E., Ladell, K., Lambe, T., Milicic, A., Price, D.A., and Hill, A.V. (2012). A T cell-inducing influenza vaccine for the elderly: Safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0048322"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s15010-013-0546-4","article-title":"Development of universal influenza vaccines based on influenza virus M and NP genes","volume":"42","author":"Zheng","year":"2014","journal-title":"Infection"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_128","first-page":"818","article-title":"Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"Carragher","year":"2008","journal-title":"J. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"13418","DOI":"10.1128\/JVI.01219-14","article-title":"Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques","volume":"88","author":"Florek","year":"2014","journal-title":"J. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Vanderven, H.A., Liu, L., Ana-Sosa-Batiz, F., Nguyen, T.H., Wan, Y., Wines, B., Hogarth, P.M., Tilmanis, D., Reynaldi, A., and Parsons, M.S. (2017). Fc functional antibodies in humans with severe H7N9 and seasonal influenza. JCI Insight, 2.","DOI":"10.1172\/jci.insight.92750"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e16578","DOI":"10.7554\/eLife.16578","article-title":"Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching","volume":"5","author":"Horns","year":"2016","journal-title":"Elife"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bbrc.2018.07.129","article-title":"Vaccine based on antibody-dependent cell-mediated cytotoxicity epitope on the H1N1 influenza virus increases mortality in vaccinated mice","volume":"503","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_134","first-page":"2604","article-title":"Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer","volume":"15","author":"Nakajima","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2217\/imt.12.38","article-title":"Combination strategies to enhance antitumor ADCC","volume":"4","author":"Kohrt","year":"2012","journal-title":"Immunotherapy"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1073\/pnas.0508123103","article-title":"Engineered antibody Fc variants with enhanced effector function","volume":"103","author":"Lazar","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e24677","DOI":"10.4161\/onci.24677","article-title":"TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR(+) head and neck cancer cells","volume":"2","author":"Stephenson","year":"2013","journal-title":"Oncoimmunology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4049\/jimmunol.175.3.1619","article-title":"CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells","volume":"175","author":"Roda","year":"2005","journal-title":"J. Immunol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1073\/pnas.1016048108","article-title":"Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure","volume":"108","author":"Chung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.1128\/JVI.00287-12","article-title":"Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding","volume":"86","author":"Klein","year":"2012","journal-title":"J. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"15773","DOI":"10.1074\/jbc.273.25.15773","article-title":"Membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor","volume":"273","author":"Boge","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: Weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J. Immunol."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Jegaskanda, S. (2018). The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine. Vaccines, 6.","DOI":"10.3390\/vaccines6020027"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1084\/jem.20181624","article-title":"Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies","volume":"216","author":"Kosik","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/276\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:03:04Z","timestamp":1760173384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":145,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["v12030276"],"URL":"https:\/\/doi.org\/10.3390\/v12030276","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}